Recent Quarter Total Invested
$310,094
Recent Quarter Institutional Ownership Percentage
2.62%
Total Invested of Last Quarter
$268,054
Ownership Percentage of Last Quarter
2.86%
Monopar Therapeutics Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 194,298 | $145,335 | 1.00% | 1.22% |
GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 60,036 | $44,906 | 45.72% | 0.38% |
TWO SIGMA SECURITIES, LLC | 08/14/2024 | 47,058 | $34,357 | 100.00% | 0.29% |
VANGUARD GROUP INC | 08/13/2024 | 45,167 | $32,976 | 0.00% | 0.28% |
GERBER, LLC | 07/22/2024 | 28,005 | $20,446 | 0.00% | 0.18% |
VIRTU FINANCIAL LLC | 08/09/2024 | 18,840 | $14,000 | -20.93% | 0.12% |
RAPPAPORT REICHES CAPITAL MANAGEMENT, LLC | 07/18/2024 | 10,695 | $7,808 | 0.00% | 0.07% |
TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 7,922 | $5,783 | 0.84% | 0.05% |
NEWEDGE ADVISORS, LLC | 08/16/2024 | 3,000 | $2,190 | 0.00% | 0.02% |
WELLS FARGO & COMPANY/MN | 08/13/2024 | 2,500 | $1,825 | 62.65% | 0.02% |
BANK OF AMERICA CORP /DE/ | 08/14/2024 | 561 | $410 | 12.20% | 0.00% |
FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 08/14/2024 | 80 | $58 | 0.00% | 0.00% |
FMR LLC | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
MORGAN STANLEY | 10/17/2024 | 0 | $0 | -100.00% | 0.00% |
HRT FINANCIAL LP | 08/12/2024 | 0 | $0 | -100.00% | 0.00% |
UBS GROUP AG | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
Monopar Therapeutics Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of MNPR shares?
During the previous two years, 18 institutional investors and hedge funds held shares of Monopar Therapeutics Inc.. The most heavily invested institutionals were:
Rappaport Reiches Capital Management, LLC: 0
GERBER, LLC: 0
MILLENNIUM MANAGEMENT LLC: 194,298
GEODE CAPITAL MANAGEMENT, LLC: 60,036
TWO SIGMA SECURITIES, LLC: 47,058
VANGUARD GROUP INC: 45,167
-
What percentage of Monopar Therapeutics Inc. stock is owned by institutional investors?
2.62% of Monopar Therapeutics Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at MNPR ?
Institutional investors have bought a total of 379,472 shares in the last 24 months. This purchase volume represents approximately $5.95 M in transactions.